BridgeMD
New treatment option for Cross Bite
Official title Impact of Anterior Cross Bite Treatment on Children's Speech Performance
ClinicalTrials.gov ID: NCT06168695
What this study is testing
- What it's testing
- The goal of this prospective, single-arm clinical trial is to evaluate the speech performance of children with anterior dental crossbite before and after correction. Also, to assess the impact of early interceptive orthodontic treatment in the mixed dentition stage to correct the anterior dental crossbite on the quality of life of children.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 8 to 10
You may be able to join if
- healthy cooperative children aged 8-10 years
- have at least one or more maxillary permanent incisors in a crossbite relationship
- fully erupted four first permanent molars
- Angle Class I molar relationship and Class I skeletal relationship
- the mother language of all the people was Arabic.
You likely can't join if
- Children with systemic illness or previous history of speech therapy
- children who are ill-habituated or unable to follow up
- children with previous orthodontic treatment
- uncooperative children
- Anterior skeletal or functional crossbite
- presence of sucking habits
The study team makes the final eligibility decision.
Where it's taking place
- Tanta, Gharbia Governorate, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 8 years to 10 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tanta, Gharbia Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.